|
|
|
|
|
by bduerst
2438 days ago
|
|
Market availability isn't the same as OTC distribution though. The expensive clinical regulations that creates barriers to entry for the market and leads to monopolistic incumbents is not the same to being able to buy the good with or without an prescription. The latter is tied more to remuneration from insurance companies - i.e. private insurance companies that are incentivized to not pay for prescriptions are more willing to only pay when care providers specifically order it. |
|